Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.2 (Delta)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AY.2 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.2 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.2 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.621 (Mu)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.621 (Mu)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.621 (Mu)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.621 (Mu)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.621 (Mu)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.621 (Mu)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.621 (Mu)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.621 (Mu)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LL.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
LL.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LL.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
LL.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
LL.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
LL.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
LL.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LL.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.22EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.22ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.22ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.22EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.22EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.22ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.22ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.3.13EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HK.3.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.3.13ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HK.3.13ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HK.3.13EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HK.3.13EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HK.3.13ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.3.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XCUEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XCUEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCUECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XCUECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XCUEHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XCUEHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XCUENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XCUENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.6EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.6ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.6ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JN.6EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JN.6EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used